The approval of medical cannabis export was included in an overall cannabis reform approved by the Israeli government in 2016 but was later halted due to a ministerial dispute.
In Switzerland’s cities, the stuff has quickly become ubiquitous—standard fare in pharmacies, convenience stores, and a new crop of dispensaries.
Researchers here in the U.S. are eager to run trials with high quality Israeli cannabis strains they cannot get anywhere else.
The Swiss legislature is considering a bill that would allow Cannabis research as well as a trial program for Amsterdam-style cannabis cafés in the European country, writes Calvin Hughes.
Dutch officials have announced a three-phase “experiment” to legally supply the Netherlands’ cannabis coffee shops with products.
Thinking of visiting Australia? This country might be the next to pass major marijuana law reforms.
The CannaTech Conference was just held March 18-21, 2018, in Tel Aviv, Israel. The conference was about as comprehensive as a medical cannabis conference
Cannabis could soon be legal in Switzerland. The Swiss Council of States, Switzerland’s smaller chamber of parliament, unanimously approved a bill allowing studies and pilot programs in the landlocked Alpine nation. The Council called for an experimental article in the Swiss Federation’s Narcotics Act that would allow for scientific research projects including trials of a “coffee shop” system of cannabis distribution similar to that of Amsterdam. Five Swiss cities have already called for such coffeeshop pilot programs.
The federal government says that Canadians generally support its planned approach to the legalization of marijuana, including detailed proposals surrounding plain packaging and warning labels.
Saskatchewan is proposing to set the legal age to consume cannabis at 19 but minors caught with a small amount won't end up with a criminal record.
Copyright 2019 - 2024. WeedWorthy.com is a news division of MjLink.com, Inc.. All rights reserved. WeedWorthy
To contact the following departments, dial 1-844-420-4208 - Sales: Ext. #2 - Support: Ext. #3 - Investor Relations: Ext. #6
By using this website, you agree and understand that, by law: You MUST be at least 21 years of age to view any content on this website. To view the complete Terms of Use and Privacy Policy for this website, Click Here!
